Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes ...

Abstract Background High triglycerides and low levels of high density lipoprotein (HDL)-cholesterol are observed to promote tumor growth. However, whether breast cancer heterogeneity may explain the contradictory influence of triglycerides and cholesterol observed on breast cancer prognosis remains...

Full description

Bibliographic Details
Main Authors: Lofterød, Trygve, Mortensen, Elin, Nalwoga, Hawa, Wilsgaard, Tom, Frydenberg, Hanne, Risberg, Terje, Eggen, Anne, McTiernan, Anne, Aziz, Sura, Wist, Erik, Stensvold, Andreas, Reitan, Jon, Akslen, Lars, Thune, Inger
Format: Article in Journal/Newspaper
Language:unknown
Published: figshare 2018
Subjects:
Online Access:https://dx.doi.org/10.6084/m9.figshare.c.4134797
https://springernature.figshare.com/collections/Impact_of_pre-diagnostic_triglycerides_and_HDL-cholesterol_on_breast_cancer_recurrence_and_survival_by_breast_cancer_subtypes/4134797
Description
Summary:Abstract Background High triglycerides and low levels of high density lipoprotein (HDL)-cholesterol are observed to promote tumor growth. However, whether breast cancer heterogeneity may explain the contradictory influence of triglycerides and cholesterol observed on breast cancer prognosis remains unclear. Methods A population-based survival study among 464 breast cancer cases identified within the Tromsø study was conducted. Pre-diagnostic triglycerides, total-cholesterol and HDL-cholesterol were measured, and detailed clinical and histopathological data were obtained. Using tissue microarray, all breast cancer cases were reclassified into the following subtypes: Luminal A, Luminal B, HER2-enriched, and triple negative breast cancer (TNBC). Multivariable Cox proportional hazards regression models were used to study the associations between pre-diagnostic lipids and breast cancer recurrence, mortality, and survival. Results A total of 464 breast cancer patients, with mean age at diagnosis of 57.9 years, ...